Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Drugs & Aging
|
September 1, 1994
Pharmacological advances in the treatment of glaucoma
J B Serle
Survey of Ophthalmology
|
November 1, 1996
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III
J B Serle
The British Journal of Ophthalmology
|
November 13, 2001
Angle closure glaucoma secondary to hemiretinal vein occlusion
D Halikiopoulos, J B Serle
Drugs of Today (Barcelona, Spain : 1998)
|
October 5, 2019
Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
J E Radell, J B Serle
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 1, 1991
Topically active carbonic anhydrase inhibitors for glaucoma
S M Podos, J B Serle
Australian and New Zealand Journal of Ophthalmology
|
May 1, 1989
Experimental compounds to lower intraocular pressure
S M Podos, C B Camras, J B Serle
American Journal of Ophthalmology
|
September 15, 1991
A clinical trial of metipranolol, a noncardioselective beta-adrenergic antagonist, in ocular hypertension
J B Serle, J S Lustgarten, S M Podos
Japanese Journal of Ophthalmology
|
May 20, 1998
A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes
J B Serle, S M Podos, Y Kitazawa, et al.
Current Eye Research
|
February 1, 1990
The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys
R F Wang, J B Serle, S M Podos, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
April 1, 1990
The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys
R F Wang, J B Serle, S M Podos, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Drugs & Aging
|
September 1, 1994
Pharmacological advances in the treatment of glaucoma
J B Serle
Survey of Ophthalmology
|
November 1, 1996
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III
J B Serle
The British Journal of Ophthalmology
|
November 13, 2001
Angle closure glaucoma secondary to hemiretinal vein occlusion
D Halikiopoulos, J B Serle
Drugs of Today (Barcelona, Spain : 1998)
|
October 5, 2019
Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
J E Radell, J B Serle
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 1, 1991
Topically active carbonic anhydrase inhibitors for glaucoma
S M Podos, J B Serle
Australian and New Zealand Journal of Ophthalmology
|
May 1, 1989
Experimental compounds to lower intraocular pressure
S M Podos, C B Camras, J B Serle
American Journal of Ophthalmology
|
September 15, 1991
A clinical trial of metipranolol, a noncardioselective beta-adrenergic antagonist, in ocular hypertension
J B Serle, J S Lustgarten, S M Podos
Japanese Journal of Ophthalmology
|
May 20, 1998
A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes
J B Serle, S M Podos, Y Kitazawa, et al.
Current Eye Research
|
February 1, 1990
The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys
R F Wang, J B Serle, S M Podos, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
April 1, 1990
The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys
R F Wang, J B Serle, S M Podos, et al.
Page
of 3